IL137295A - History of spiropipridine and pharmaceutical preparations containing them - Google Patents

History of spiropipridine and pharmaceutical preparations containing them

Info

Publication number
IL137295A
IL137295A IL13729599A IL13729599A IL137295A IL 137295 A IL137295 A IL 137295A IL 13729599 A IL13729599 A IL 13729599A IL 13729599 A IL13729599 A IL 13729599A IL 137295 A IL137295 A IL 137295A
Authority
IL
Israel
Prior art keywords
sub
ch2ch2
bond
groups
group
Prior art date
Application number
IL13729599A
Other languages
English (en)
Hebrew (he)
Other versions
IL137295A0 (en
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of IL137295A0 publication Critical patent/IL137295A0/xx
Publication of IL137295A publication Critical patent/IL137295A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/428Thiazoles condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/60Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
IL13729599A 1998-01-23 1999-01-22 History of spiropipridine and pharmaceutical preparations containing them IL137295A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP1111298 1998-01-23
JP13295998 1998-05-15
PCT/JP1999/000226 WO1999037642A1 (en) 1998-01-23 1999-01-22 Spiropiperidine derivatives

Publications (2)

Publication Number Publication Date
IL137295A0 IL137295A0 (en) 2001-07-24
IL137295A true IL137295A (en) 2005-12-18

Family

ID=26346503

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13729599A IL137295A (en) 1998-01-23 1999-01-22 History of spiropipridine and pharmaceutical preparations containing them

Country Status (21)

Country Link
US (1) US6511975B1 (da)
EP (1) EP1057827B1 (da)
KR (1) KR100629672B1 (da)
CN (1) CN1165533C (da)
AT (1) ATE249455T1 (da)
AU (1) AU741924B2 (da)
BR (1) BR9907173A (da)
CA (1) CA2318361A1 (da)
DE (1) DE69911176T2 (da)
DK (1) DK1057827T3 (da)
ES (1) ES2203061T3 (da)
HK (1) HK1032780A1 (da)
HU (1) HUP0100939A3 (da)
ID (1) ID25477A (da)
IL (1) IL137295A (da)
MX (1) MXPA00007240A (da)
NO (1) NO317979B1 (da)
NZ (1) NZ505599A (da)
PT (1) PT1057827E (da)
TR (1) TR200002072T2 (da)
WO (1) WO1999037642A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005080339A1 (ja) * 2004-02-25 2005-09-01 Sankyo Company, Limited スルホニルオキシ誘導体
KR20060127157A (ko) 2004-02-25 2006-12-11 상꾜 가부시키가이샤 인다놀 유도체
EA014239B1 (ru) * 2005-03-08 2010-10-29 Янссен Фармацевтика Н.В. Производные диаза-спиро-[4,4]нонана в качестве антагонистов нейрокинина (nk1)
US8224647B2 (en) 2005-10-03 2012-07-17 Nuance Communications, Inc. Text-to-speech user's voice cooperative server for instant messaging clients
PT2913326T (pt) 2008-05-14 2020-08-24 Scripps Research Inst Novos moduladores de recetores de fosfato de esfingosina
MX2011009700A (es) 2009-03-17 2011-12-08 Daiichi Sankyo Co Ltd Derivado de amida.
MY189750A (en) * 2009-11-13 2022-03-02 Receptos Llc Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis
AU2010319982B2 (en) * 2009-11-13 2016-02-04 Receptos Llc Selective heterocyclic sphingosine 1 phosphate receptor modulators
MY160907A (en) * 2009-11-13 2017-03-31 Receptos Inc Sphingosine 1 phosphate receptor modulators and methods of chiral synthesis
EP2484674A1 (en) * 2011-02-02 2012-08-08 Rottapharm S.P.A. Spiro aminic compounds with NK1 antagonist activity
WO2012158550A2 (en) 2011-05-13 2012-11-22 Receptos, Inc. Selective heterocyclic sphingosine 1 phosphate receptor modulators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2119174T3 (es) * 1993-01-28 1998-10-01 Merck & Co Inc Azaciclos espiro-sustituidos como antagonistas de los receptores de las taquiquininas.
RU2135494C1 (ru) 1995-12-01 1999-08-27 Санкио Компани Лимитед Гетероциклические соединения и композиция на их основе, проявляющая антагонистическое действие в отношении рецепторов тахикинина
JP3192631B2 (ja) * 1997-05-28 2001-07-30 三共株式会社 飽和複素環化合物からなる医薬
PT987269E (pt) * 1997-05-30 2003-11-28 Sankyo Co Sais de derivados sulfoxido opticamente activo

Also Published As

Publication number Publication date
WO1999037642A1 (en) 1999-07-29
AU741924B2 (en) 2001-12-13
EP1057827A4 (en) 2001-11-21
EP1057827A1 (en) 2000-12-06
NO20003630D0 (no) 2000-07-14
DE69911176D1 (de) 2003-10-16
BR9907173A (pt) 2000-10-10
DK1057827T3 (da) 2004-01-26
HUP0100939A3 (en) 2002-06-28
AU2073999A (en) 1999-08-09
KR100629672B1 (ko) 2006-09-29
PT1057827E (pt) 2003-11-28
IL137295A0 (en) 2001-07-24
NO20003630L (no) 2000-09-20
ATE249455T1 (de) 2003-09-15
KR20010034280A (ko) 2001-04-25
ES2203061T3 (es) 2004-04-01
US6511975B1 (en) 2003-01-28
HK1032780A1 (en) 2001-08-03
CA2318361A1 (en) 1999-07-29
HUP0100939A2 (hu) 2002-05-29
EP1057827B1 (en) 2003-09-10
CN1294588A (zh) 2001-05-09
NZ505599A (en) 2003-06-30
CN1165533C (zh) 2004-09-08
ID25477A (id) 2000-10-05
DE69911176T2 (de) 2004-06-24
NO317979B1 (no) 2005-01-17
MXPA00007240A (es) 2002-05-08
TR200002072T2 (tr) 2000-12-21

Similar Documents

Publication Publication Date Title
US5830892A (en) Piperidine and morphonline derivatives and their use as therapeutic agents
EP1057827B1 (en) Spiropiperidine derivatives
BG64703B1 (bg) Полиморфна форма на 2-(r)-(1-(r)-(3,5-бис(трифлуорометил) фенил)етокси)-3-(s)-(4-флуоро)-фенил-4-(3-(5-оксо-1н,4н- 1,2,4-триазоло)метилморфолин, метод за нейното получаване и фармацевтични състави, които я съдържат
EP1551803A1 (en) Azabicyclo derivatives as muscarinic receptor antagonists
WO2001029027A1 (fr) Dérivés de 2-alcoxybenzène
JP2002316987A (ja) 2−アルコキシベンゼン誘導体を含有する医薬
WO1996031469A1 (en) N-substituted azaheterocyclic carboxylic acids and esters thereof
EP0841923B1 (en) 1h-4(5)-substituted imidazole derivatives
JP2000034288A (ja) スピロピペリジン誘導体
ES2243012T3 (es) Derivados heterociclicos aliciclicos acilados.
RU2184735C2 (ru) Производные спиропиперидина, лекарственное средство, способ профилактики или лечения
JP2001031570A (ja) スピロピペリジン誘導体を含有する医薬
JP3017147B2 (ja) 光学活性スルホキシド誘導体
CZ20002503A3 (cs) Spiropiperidinové deriváty
JPH11240880A (ja) 脂環式アシル化複素環誘導体
JP2001187790A (ja) 2−アルコキシベンゼン誘導体
JP2000229968A (ja) シクロヘキシルピペリジン誘導体
RU2174122C1 (ru) Ацилированные гетероалициклические производные, лекарственное средство, обладающее селективной антагонистической активностью против nk2-рецепторов, способ профилактики или лечения заболевания
JP2000344670A (ja) 脂環式アシル化複素環誘導体を含有する医薬
JP2000103791A (ja) 医薬合成のための光学活性スルホキシド誘導体
MXPA00005587A (en) Alicyclic acylated heterocyclic derivatives
KR100484358B1 (ko) 타키키닌 수용체 길항 작용을 갖는 헤테로시클릭 화합물, 그 의 제법 및 그의 용도
JPH10182650A (ja) 光学活性スルホキシド誘導体
CZ20002051A3 (cs) Acylované hetero-alicyklické deriváty
JPH0867675A (ja) ビニルチアゾール誘導体

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed